134979-01-4 Usage
Uses
Used in Biochemistry:
2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride is used as a potential interacting agent for proteins due to its amino acid derivative nature, which allows it to potentially form complexes or participate in biochemical processes.
Used in Organic Chemistry:
2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride is used as a versatile molecule for chemical reactions, taking advantage of its multiple functional groups, which can be manipulated to synthesize a variety of compounds.
Used in Peptide Synthesis:
2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride is used as a building block in peptide synthesis, where its amino acid derivative structure can be incorporated into larger peptide chains for the development of bioactive molecules or pharmaceuticals.
Used in Drug Delivery Systems:
2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride is used as a component in the development of drug delivery systems, where its chemical properties may be exploited to improve the delivery, bioavailability, and therapeutic outcomes of various drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 134979-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,9,7 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 134979-01:
(8*1)+(7*3)+(6*4)+(5*9)+(4*7)+(3*9)+(2*0)+(1*1)=154
154 % 10 = 4
So 134979-01-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO4.ClH/c7-1-2-10-3-4-11-5-6(8)9;/h1-5,7H2,(H,8,9);1H
134979-01-4Relevant academic research and scientific papers
EXENATIDE MODIFIER AND USE THEREOF
-
Paragraph 0241, (2018/05/24)
Disclosed are an exenatide modifier for connecting the exenatide to a fatty chain with a carboxy in the terminus thereof by means of a hydrophilic connecting arm, and a use thereof in preparing drugs serving as a GLP-1 receptor agonist; a use in preparing drugs for preventing and/or treating diseases and/or symptoms associated with a low GLP-1 receptor activity; a use in preparing drugs for diseases and/or symptoms associated with glycometabolism; a use in preparing drugs for diabetes; a use in preparing drugs for fatty liver disease, and a use in preparing drugs for losing weight.
THE SYNTHESIS OF GLYCOLIPIDS CONTAINING A HYDROPHILIC SPACER-GROUP
Slama, James,Rando, Robert R.
, p. 213 - 222 (2007/10/02)
Cholesterol-containing glycolipids incorporating a new hydrophilic specer-group, 8-amino-3,6-dioxaoctanoic acid, were synthesized.This spacer group eliminates many of the problems inherent in the use of hydrophobic or charged, spacer arms.
